nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Bayesian Quantitative Disease–Drug–Trial Models for Parkinson’s Disease to Guide Early Drug Development
|
Lee, Joo Yeon |
|
2011 |
13 |
4 |
p. 508-518 |
artikel |
2 |
BDDCS Applied to Over 900 Drugs
|
Benet, Leslie Z. |
|
2011 |
13 |
4 |
p. 519-547 |
artikel |
3 |
Bilirubin—A Potential Marker of Drug Exposure in Atazanavir-Based Antiretroviral Therapy
|
Rekić, Dinko |
|
2011 |
13 |
4 |
p. 598-605 |
artikel |
4 |
Biomarkers for Drug-Induced Renal Damage and Nephrotoxicity—An Overview for Applied Toxicology
|
Fuchs, Tobias Christian |
|
2011 |
13 |
4 |
p. 615-631 |
artikel |
5 |
Comparative Performance of Cell Life Span and Cell Transit Models for Describing Erythropoietic Drug Effects
|
Budha, Nageshwar R. |
|
2011 |
13 |
4 |
p. 650-661 |
artikel |
6 |
Differential Metabolism of Organic Nitrates by Aldehyde Dehydrogenase 1a1 and 2: Substrate Selectivity, Enzyme Inactivation, and Active Cysteine Sites
|
Tsou, Pei-Suen |
|
2011 |
13 |
4 |
p. 548-555 |
artikel |
7 |
Epigenetic CpG Demethylation of the Promoter and Reactivation of the Expression of Neurog1 by Curcumin in Prostate LNCaP Cells
|
Shu, Limin |
|
2011 |
13 |
4 |
p. 606-614 |
artikel |
8 |
Erratum to: Modeling the Effects of Vaccination and Treatment on Pandemic Influenza
|
Feng, Zhilan |
|
2011 |
13 |
4 |
p. 674 |
artikel |
9 |
Factors Influencing the Use and Interpretation of Animal Models in the Development of Parenteral Drug Delivery Systems
|
Martinez, Marilyn N. |
|
2011 |
13 |
4 |
p. 632-649 |
artikel |
10 |
Harmonization of Regulatory Approaches for Evaluating Therapeutic Equivalence and Interchangeability of Multisource Drug Products: Workshop Summary Report
|
Chen, Mei-Ling |
|
2011 |
13 |
4 |
p. 556-564 |
artikel |
11 |
Holford NHG and Sheiner LB “Understanding the Dose-Effect Relationship-Clinical Application of Pharmacokinetic-Pharmacodynamic Models”, Clin Pharmacokin 6:429–453 (1981)—The Backstory
|
Holford, Nick |
|
2011 |
13 |
4 |
p. 662-664 |
artikel |
12 |
Optimal Design in Population Kinetic Experiments by Set-Valued Methods
|
Gennemark, Peter |
|
2011 |
13 |
4 |
p. 495-507 |
artikel |
13 |
Pharmacodynamic Model of Sodium–Glucose Transporter 2 (SGLT2) Inhibition: Implications for Quantitative Translational Pharmacology
|
Maurer, Tristan S. |
|
2011 |
13 |
4 |
p. 576-584 |
artikel |
14 |
Population Pharmacokinetics of Telapristone (CDB-4124) and its Active Monodemethylated Metabolite CDB-4453, with a Mixture Model for Total Clearance
|
Morris, Denise |
|
2011 |
13 |
4 |
p. 665-673 |
artikel |
15 |
Quantitative PK–PD Model-Based Translational Pharmacology of a Novel Kappa Opioid Receptor Antagonist Between Rats and Humans
|
Chang, Cheng |
|
2011 |
13 |
4 |
p. 565-575 |
artikel |
16 |
Relationships between Liposome Properties, Cell Membrane Binding, Intracellular Processing, and Intracellular Bioavailability
|
Li, Yinghuan |
|
2011 |
13 |
4 |
p. 585-597 |
artikel |